SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-150328
Filing Date
2024-05-30
Accepted
2024-05-30 16:06:36
Documents
6
Effectiveness Date
2024-05-30

Document Format Files

Seq Description Document Type Size
1 S-8 d843249ds8.htm S-8 34391
2 EX-5.1 d843249dex51.htm EX-5.1 8249
3 EX-23.2 d843249dex232.htm EX-23.2 1767
4 EX-FILING FEES d843249dexfilingfees.htm EX-FILING FEES 15308
5 GRAPHIC g843249g0529073512177.jpg GRAPHIC 1579
6 GRAPHIC g843249g0529073512443.jpg GRAPHIC 5840
  Complete submission text file 0001193125-24-150328.txt   71321
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279823 | Film No.: 241005226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)